It is a tumor suppressor gene, with loss of function mutations in VS [11], leading to overexpression of Neuregulin 1 (NDRG1), which in turn activates ERK- and AKT-signaling pathways in VS, promoting VS cell proliferation [12–14]. This evidence concerns the gene NRG1 and neoplasm.